You searched for "Dundee"
Outcomes of strabismus surgery for TED
This study investigated the surgical outcome according to the initial postoperative angle of deviation after strabismus surgery in patients with hypotropia and esotropia who had thyroid eye disease (TED). The study included 78 patients with mean age of 53.4 ±9.5...
Two-year results of a T&E aflibercept regime in caucasian PNV
4 October 2023
| Su Young
|
EYE - Vitreo-Retinal
This a retrospective study examining two-year outcomes of patients with pachychoroid neovasculopathy (PNV) treated with a treat and extend (T&E) regimen of intravitreal aflibercept. The mean age was 63.84 ± 7.92 years with nine males (35%) and 17 females (65%)....
Ophthalmology in the developing world
1 April 2014
| Caterina Sarah Dal Col
|
EYE - General
After the second year of medical school, I spent my summer vacation working as a volunteer for a small Italian non-government organisation (NGO), named HEALTH-AID. As part of my volunteering experience, I joined a team of European doctors, medical students...
‘The Way Forward’ champions clinicians as architects of patient-centred service redesign
The demographic time bomb poses the dilemma of how more healthcare can be delivered to the UK’s ageing population without commensurate growth in resources. The Way Forward Project provides a robust resource for clinical centres to better identify and implement...Situation analysis of diabetic retinopathy services in eleven countries
1 December 2015
| Peter Blows, Tunde Peto, Heiko Philippin, Marcia Zondervan
|
EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
A five-year project funded by The Queen Elizabeth Diamond Jubilee Trust is facilitating development of diabetic retinopathy services (DRS) to reduce unnecessary blindness in 10 Commonwealth countries through the establishment of a capacity-building network, the DR-NET part of the Commonwealth...
Ophthalmology elective in China
2 April 2025
| Grace Loy
|
EYE - General
Wandering through the bustling streets of Zhejiang, China, immersed in the harmonious blend of modernity and tradition, I made my way to the Eye Centre of the Second Affiliated Hospital, Zhejiang University College of Medicine. The aroma of traditional Chinese...
More sensitive visual acuity test for age-related macular degeneration
1 October 2016
| Roger S Anderson (Prof), Nilpa Shah
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world. Primarily associated with ageing, genetic factors and lifestyle choices such as smoking also play a contributory role. Patients with early AMD, characterised by the development of...
AI breakthrough brings geographic atrophy treatment a step closer
20 September 2021
A team led by Dr Konstantinos Balaskas at Moorfields Eye Hospital Reading Centre has developed a fully automated, deep-learning model (algorithm) that can detect and quantify geographic atrophy using standard optical coherence tomography (OCT) scans.
RNIB and British Blind Sport join forces to tackle the disparity of physical activity amongst blind and partially sighted people
The UK’s leading sight loss charity, Royal National Institute of Blind People (RNIB) and British Blind Sport have joined forces to launch the See Sport Differently campaign, which aims to promote accessible sports and breakdown barriers faced by blind and partially sighted people who want to get active.Half a million factory workers in low-income countries have vision screened in landmark project led by alliance of US Businesses
Half a million factory workers in low-income countries have vision screened in landmark project led by alliance of US Businesses – a milestone announced today, World Sight Day.Optegra launches new junior doctor training
Eye hospital group Optegra has further increased its support of the NHS with a new training scheme for NHS junior doctors.LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation
1 February 2024
|
ISS, retinal, artificial, LambdaVision, industry, innovation, retinitis pigmentosa, RP
Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...
